These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 28359194)

  • 21. Data monitoring committee interim reports: We must get there soon!
    DeMets DL; Wittes J
    Clin Trials; 2022 Feb; 19(1):107-111. PubMed ID: 34693741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Independent academic Data Monitoring Committees for clinical trials in cardiovascular and cardiometabolic diseases.
    Filippatos GS; de Graeff P; Bax JJ; Borg JJ; Cleland JG; Dargie HJ; Flather M; Ford I; Friede T; Greenberg B; Henon-Goburdhun C; Holcomb R; Horst B; Lekakis J; Mueller-Velten G; Papavassiliou AG; Prasad K; Rosano GM; Severin T; Sherman W; Stough WG; Swedberg K; Tavazzi L; Tousoulis D; Vardas P; Ruschitzka F; Anker SD
    Eur J Heart Fail; 2017 Apr; 19(4):449-456. PubMed ID: 28271595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. "You have to keep your nerve on a DMC." Challenges for Data Monitoring Committees in neonatal intensive care trials: Qualitative accounts from the BRACELET Study.
    Snowdon C; Brocklehurst P; Tasker RC; Ward Platt M; Elbourne D
    PLoS One; 2018; 13(7):e0201037. PubMed ID: 30048484
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Data and safety monitoring policy for National Institute of Allergy and Infectious Diseases clinical trials.
    Dixon DO; Weiss S; Cahill K; Fox L; Love J; McNamara J; Soto-Torres LE
    Clin Trials; 2011 Dec; 8(6):727-35. PubMed ID: 22024105
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Independent data monitoring committees: an update and overview.
    Sartor O; Halabi S
    Urol Oncol; 2015 Mar; 33(3):143-8. PubMed ID: 25631301
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monitoring clinical trials: issues and controversies regarding confidentiality.
    Fleming TR; Ellenberg S; DeMets DL
    Stat Med; 2002 Oct; 21(19):2843-51. PubMed ID: 12325100
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A model for the interim analysis process: a case study.
    Delgado-Herrera L; Anbar D
    Control Clin Trials; 2003 Feb; 24(1):51-65. PubMed ID: 12559642
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Data monitoring and interim analyses in the pharmaceutical industry: ethical and logistical considerations.
    Rockhold FW; Enas GG
    Stat Med; 1993 Mar; 12(5-6):471-9. PubMed ID: 8493425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trial Steering Committees in randomised controlled trials: A survey of registered clinical trials units to establish current practice and experiences.
    Conroy EJ; Harman NL; Lane JA; Lewis SC; Murray G; Norrie J; Sydes MR; Gamble C
    Clin Trials; 2015 Dec; 12(6):664-76. PubMed ID: 26085545
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of the Data and Safety Monitoring Committee (DSMC).
    Wilhelmsen L
    Stat Med; 2002 Oct; 21(19):2823-9. PubMed ID: 12325098
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Should statisticians reporting to data monitoring committees be independent of the trial sponsor and leadership?
    Ellenberg SS; George SL
    Stat Med; 2004 May; 23(10):1503-5. PubMed ID: 15122727
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Developing training for Data Safety Monitoring Board members: A National Institute of Allergy and Infectious Diseases case study.
    Zuckerman J; van der Schalie B; Cahill K
    Clin Trials; 2015 Dec; 12(6):688-91. PubMed ID: 26152835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The project data sphere initiative: accelerating cancer research by sharing data.
    Green AK; Reeder-Hayes KE; Corty RW; Basch E; Milowsky MI; Dusetzina SB; Bennett AV; Wood WA
    Oncologist; 2015 May; 20(5):464-e20. PubMed ID: 25876994
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Standard Operating Procedures for Chinese Medicine Data Monitoring Committees of Clinical Studies.
    Liu J; Wang N; Dang HX; Chen BW; Zhang L; Zou C; Zhong CL; Huang JK; Liu Q; Yu YN; Jiang M; Liang WX; Chen QG; Wang YY; Shen CT; Wang Z;
    Chin J Integr Med; 2021 Jul; 27(7):483-489. PubMed ID: 33170939
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Data monitoring committees: the moral case for maximum feasible independence.
    Walters L
    Stat Med; 1993 Mar; 12(5-6):575-80; discussion 581-2. PubMed ID: 8493433
    [TBL] [Abstract][Full Text] [Related]  

  • 36. What are the roles and valued attributes of a Trial Steering Committee? Ethnographic study of eight clinical trials facing challenges.
    Daykin A; Selman LE; Cramer H; McCann S; Shorter GW; Sydes MR; Gamble C; Macefield R; Lane JA; Shaw A
    Trials; 2016 Jul; 17(1):307. PubMed ID: 27369866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of independent data-monitoring committees in randomized clinical trials sponsored by the National Cancer Institute.
    Smith MA; Ungerleider RS; Korn EL; Rubinstein L; Simon R
    J Clin Oncol; 1997 Jul; 15(7):2736-43. PubMed ID: 9215848
    [TBL] [Abstract][Full Text] [Related]  

  • 38. On independent data monitoring committees in oncology clinical trials.
    Wittes J; Schactman M
    Chin Clin Oncol; 2014 Sep; 3(3):40. PubMed ID: 25841466
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An overview of trends in the regulation of clinical ethics committees: an opinion from the Italian National Bioethics Committee article.
    Montanari Vergallo G; Petrini C
    Cuad Bioet; 2018; 29(97):221-231. PubMed ID: 30380897
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sharing interim trial results by the Data Safety Monitoring Board with those responsible for the trial's conduct and progress: a narrative review.
    Borg Debono V; Mbuagbaw L; Thabane L
    Trials; 2017 Mar; 18(1):120. PubMed ID: 28279205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.